期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Artificial intelligence empowering the full spectrum of drug discovery
1
作者 Tingting Fu Kuo Zhang +2 位作者 Tingjun Hou Caisheng Wu Feng Zhu 《Journal of Pharmaceutical Analysis》 2025年第8期1687-1689,共3页
Drug discovery is a complex and highly systematic process encompassing multiple critical stages,including target identification,bioactive molecule discovery,preclinical research,clinical trials,regulatory review,post-... Drug discovery is a complex and highly systematic process encompassing multiple critical stages,including target identification,bioactive molecule discovery,preclinical research,clinical trials,regulatory review,post-marketing surveillance,and others[1].This process typically spans many years and is often accompanied by high failure rates and substantial resource consumption.In recent years,driven by large amounts of biomedical data,artificial intelligence(AI)has begun to reshape every stage of drug discovery[2].Particularly,by integrating diverse,high-dimensional datasets with powerful predictive and generative models. 展开更多
关键词 CLINICALTRIALS DRUGDISCOVERY drug discovery target identificationbioactive molecule discoverypreclinical researchclinical trialsregulatory targetidentification bioactive moleculediscovery biomedical dataartificial intelligence ai preclinicalresearch
在线阅读 下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部